TGF-β1 presenting enzymatically cross-linked injectable hydrogels for improved chondrogenesis

Colloids and Surfaces B: Biointerfaces

Volumn 159, Issue , 2017, Pages 838-848

  Arora, Aditya ^a   Mahajan, Aman ^a   Katti, Dhirendra S ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY KANPUR   (India)

Author keywords

Carboxymethyl cellulose; Cartilage tissue engineering; Gelatin; Horseradish peroxidase; Injectable hydrogel; Sulfation; TGF delivery

Indexed keywords

CARTILAGE; CELL CULTURE; CELLULOSE; COST EFFECTIVENESS; COST ENGINEERING; DEPOSITION; FLOWCHARTING; SULFUR COMPOUNDS; TISSUE; TISSUE ENGINEERING;

CARBOXY-METHYL CELLULOSE; CARTILAGE TISSUE ENGINEERING; GELATIN; HORSE-RADISH PEROXIDASE; INJECTABLE HYDROGELS; SULFATION;

HYDROGELS;

CARBOXYMETHYLCELLULOSE; GELATIN; TRANSFORMING GROWTH FACTOR BETA1; HEPARAN SULFATE; HORSERADISH PEROXIDASE; HYDROGEN PEROXIDE;

ARTICLE; CARTILAGE; CELL SURVIVAL; CHONDROGENESIS; CONTROLLED STUDY; HYDROGEL; IMMOBILIZATION; IN VITRO STUDY; LIMIT OF QUANTITATION; NANOENCAPSULATION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN FUNCTION; TISSUE ENGINEERING; TURBIDIMETRY; CHEMISTRY; DRUG EFFECT; METABOLISM; PROCEDURES;

CARBOXYMETHYL CELLULOSE; CELLS; COLLAGEN; CROSS LINKING; GELS;

CARBOXYMETHYLCELLULOSE SODIUM; CHONDROGENESIS; GELATIN; HEPARITIN SULFATE; HORSERADISH PEROXIDASE; HYDROGELS; HYDROGEN PEROXIDE; TISSUE ENGINEERING; TRANSFORMING GROWTH FACTOR BETA1;

EID: 85028848216     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2017.08.035     Document Type: Article

References (38)

1. Zhang, L., Hu, J., Athanasiou, K.A., The role of tissue engineering in articular cartilage repair and regeneration. Crit. Rev. Biomed. Eng. 37:1-2 (2009), 1–57.
2. Falah, M., Nierenberg, G., Soudry, M., Hayden, M., Volpin, G., Treatment of articular cartilage lesions of the knee. Int. Orthop. 34:5 (2010), 621–630.
3. Leijten, J.C., Georgi, N., Wu, L., van Blitterswijk, C.A., Karperien, M., Cell sources for articular cartilage repair strategies: shifting from monocultures to cocultures. Tissue Eng. Part B Rev 19:1 (2012), 31–40.
4. Schnabel, M., Marlovits, S., Eckhoff, G., Fichtel, I., Gotzen, L., Vecsei, V., Schlegel, J., Dedifferentiation-associated changes in morphology and gene expression in primary human articular chondrocytes in cell culture. Osteoarthr. Cartil. 10:1 (2002), 62–70.
5. Matricali, G.A., Dereymaeker, G., Luyten, F.P., Donor site morbidity after articular cartilage repair procedures: a review. Acta Orthop. Belg., 76(5), 2010, 669.
6. Jin, H.J., Bae, Y.K., Kim, M., Kwon, S.-J., Jeon, H.B., Choi, S.J., Kim, S.W., Yang, Y.S., Oh, W., Chang, J.W., Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy. Int. J. Mol. Sci. 14:9 (2013), 17986–18001.
7. Pelttari, K., Winter, A., Steck, E., Goetzke, K., Hennig, T., Ochs, B.G., Aigner, T., Richter, W., Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in scid mice. Arthritis Rheum. 54:10 (2006), 3254–3266.
8. Arora, A., Sriram, M., Kothari, A., Katti, D.S., Co-culture of infrapatellar fat pad?derived mesenchymal stromal cells and articular chondrocytes in plasma clot for cartilage tissue engineering. Cytotherapy 19:7 (2017), 881–894.
9. Dahlin, R.L., Ni, M., Meretoja, V.V., Kasper, F.K., Mikos, A.G., TGF-β3-Induced chondrogenesis in co-cultures of chondrocytes and mesenchymal stem cells on biodegradable scaffolds. Biomaterials 35:1 (2014), 123–132.
10. Solorio, L.D., Fu, A.S., Hernández-Irizarry, R., Alsberg, E., Chondrogenic differentiation of human mesenchymal stem cell aggregates via controlled release of tgf-Β1 from incorporated polymer microspheres. J. Biomed. Mater. Res. Part A 92:3 (2010), 1139–1144.
11. Kim, H.-J., Kim, Y.-J., Im, G.-I., Is continuous treatment with transforming growth factor-beta necessary to induce chondrogenic differentiation in mesenchymal stem cells?. Cells Tissues Organs 190:1 (2008), 1–10.
12. Sakai, S., Hirose, K., Taguchi, K., Ogushi, Y., Kawakami, K., An injectable, in situ enzymatically gellable, gelatin derivative for drug delivery and tissue engineering. Biomaterials 30:20 (2009), 3371–3377.
13. Frith, J.E., Cameron, A.R., Menzies, D.J., Ghosh, P., Whitehead, D.L., Gronthos, S., Zannettino, A.C., Cooper-White, J.J., An injectable hydrogel incorporating mesenchymal precursor cells and pentosan polysulphate for intervertebral disc regeneration. Biomaterials 34:37 (2013), 9430–9440.
14. Reza, A.T., Nicoll, S.B., Characterization of novel photocrosslinked carboxymethylcellulose hydrogels for encapsulation of nucleus pulposus cells. Acta Biomater. 6:1 (2010), 179–186.
15. Pluhar, G., Turner, A., Pierce, A., Toth, C., Wheeler, D., A comparison of two biomaterial carriers for osteogenic protein-1 (Bmp-7) in an ovine critical defect model. Bone Joint J. 88:7 (2006), 960–966.
16. Nichol, J.W., Koshy, S.T., Bae, H., Hwang, C.M., Yamanlar, S., Khademhosseini, A., Cell-laden microengineered gelatin methacrylate hydrogels. Biomaterials 31:21 (2010), 5536–5544.
17. Kunou, M., Koizumi, M., Shimizu, K., Kawase, M., Hatanaka, K., Synthesis of sulfated colominic acids and their interaction with fibroblast growth factors. Biomacromolecules 1:3 (2000), 451–458.
18. Freeman, I., Kedem, A., Cohen, S., The effect of sulfation of alginate hydrogels on the specific binding and controlled release of heparin-binding proteins. Biomaterials 29:22 (2008), 3260–3268.
19. Wang, Z.M., Li, L., Zheng, B.S., Normakhamatov, N., Guo, S.Y., Preparation and anticoagulation activity of sodium cellulose sulfate. Int. J. Biol. Macromol. 41:4 (2007), 376–382.
20. Dodgson, K., Price, R., A note on the determination of the ester sulphate content of sulphated polysaccharides. Biochem. J., 84(1), 1962, 106.
21. Ogushi, Y., Sakai, S., Kawakami, K., Synthesis of enzymatically-Gellable carboxymethylcellulose for biomedical applications. J. Biosci. Bioeng. 104:1 (2007), 30–33.
22. Jin, R., Teixeira, L.S.M., Dijkstra, P.J., van Blitterswijk, C.A., Karperien, M., Feijen, J., Chondrogenesis in injectable enzymatically crosslinked heparin/dextran hydrogels. J. Controlled Release 152:1 (2011), 186–195.
23. Chen, F., Yu, S., Liu, B., Ni, Y., Yu, C., Su, Y., Zhu, X., Yu, X., Zhou, Y., Yan, D., An injectable enzymatically crosslinked carboxymethylated pullulan/chondroitin sulfate hydrogel for cartilage tissue engineering. Sci. Rep. 6 (2016), 1–12.
24. Arora, A., Kothari, A., Katti, D.S., Pericellular plasma clot negates the influence of scaffold stiffness on chondrogenic differentiation. Acta Biomater. 46 (2016), 68–78.
25. Lopa, S., Colombini, A., Stanco, D., De Girolamo, L., Sansone, V., Moretti, M., Donor-matched mesenchymal stem cells from knee infrapatellar and subcutaneous adipose tissue of osteoarthritic donors display differential chondrogenic and osteogenic commitment. Eur. Cell Mater. 27 (2014), 298–311.
26. Schmitz, N., Laverty, S., Kraus, V.B., Aigner, T., Basic methods in histopathology of joint tissues. Osteoarthr. Cartil. 18 (2010), S113–S116.
27. Labarca, C., Paigen, K., Simple, A., Rapid, and sensitive DNA assay procedure. Anal. Biochem. 102:2 (1980), 344–352.
28. Park, K.M., Lee, Y., Son, J.Y., Oh, D.H., Lee, J.S., Park, K.D., Synthesis and characterizations of in situ cross-linkable gelatin and 4-Arm-Ppo-Peo hybrid hydrogels via enzymatic reaction for tissue regenerative medicine. Biomacromolecules 13:3 (2012), 604–611.
29. Lee, J.H., Ahn, H.S., Kim, E.K., Efficacy of sodium hyaluronate and carboxymethylcellulose in treating mild to moderate dry eye disease. Cornea 30:2 (2011), 175–179.
30. Salinas, C.N., Anseth, K.S., The enhancement of chondrogenic differentiation of human mesenchymal stem cells by enzymatically regulated rgd functionalities. Biomaterials 29:15 (2008), 2370–2377.
31. Re'em, T., Kaminer-Israeli, Y., Ruvinov, E., Cohen, S., Chondrogenesis of hmsc in affinity-bound tgf-Beta scaffolds. Biomaterials 33:3 (2012), 751–761.
32. Toh, W.S., Lim, T.C., Kurisawa, M., Spector, M., Modulation of mesenchymal stem cell chondrogenesis in a tunable hyaluronic acid hydrogel microenvironment. Biomaterials 33:15 (2012), 3835–3845.
33. Wang, L.-S., Du, C., Toh, W.S., Wan, A.C., Gao, S.J., Kurisawa, M., Modulation of chondrocyte functions and stiffness-dependent cartilage repair using an injectable enzymatically crosslinked hydrogel with tunable mechanical properties. Biomaterials 35:7 (2014), 2207–2217.
34. Chung, Y.-I., Tae, G., Yuk, S.H., A facile method to prepare heparin-Functionalized nanoparticles for controlled release of growth factors. Biomaterials 27:12 (2006), 2621–2626.
35. Jha, A.K., Mathur, A., Svedlund, F.L., Ye, J., Yeghiazarians, Y., Healy, K.E., Molecular weight and concentration of heparin in hyaluronic acid-based matrices modulates growth factor retention kinetics and stem cell fate. J. Controlled Release 209 (2015), 308–316.
36. Jha, A.K., Tharp, K.M., Ye, J., Santiago-Ortiz, J.L., Jackson, W.M., Stahl, A., Schaffer, D.V., Yeghiazarians, Y., Healy, K.E., Enhanced survival and engraftment of transplanted stem cells using growth factor sequestering hydrogels. Biomaterials 47 (2015), 1–12.
37. Albro, M.B., Nims, R.J., Durney, K.M., Cigan, A.D., Shim, J.J., Vunjak-Novakovic, G., Hung, C.T., Ateshian, G.A., Heterogeneous engineered cartilage growth results from gradients of media-supplemented active tgf-Β and is ameliorated by the alternative supplementation of latent tgf-Β. Biomaterials 77 (2016), 173–185.
38. Yang, X., Chen, L., Xu, X., Li, C., Huang, C., Deng, C.-X., Tgf-Β/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. J. Cell Biol. 153:1 (2001), 35–46.